Opioid Crisis in America
Resources from the U.S. Department of Health and Human Services (HHS)
Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder in Medicare: Inequities and State Policies that Reduce Gaps (PDF)
This study analyzed associations between sociodemographic characteristics, health-related and policy-related predictors of medications for opioid use disorder utilization among Medicare Fee-for-Service enrollees with opioid use disorder in 2018.
This short highlight video features panelists from the CMS OMH Forum on Opioids: Strategies and Solutions for Minority Communities discussing the opioid epidemic in minority communities.
The CMS OMH Forum on Opioids: Strategies and Solutions for Minority Communities discussed partnerships and efforts to combat the opioid epidemic and better address behavioral health in people from minority populations. CMS OMH co-hosted the forum with the Substance Abuse and Mental Health Administration’s Office of Behavioral Health Equity.
The CMS Roadmap: Strategy to Fight the Opioid Crisis lays out CMS's three-pronged approach to combating the opioid epidemic: 1) focusing on prevention of new cases of opioid use disorder, 2) treating patients who have already become dependent on or addicted to opioids, and 3) utilizing data from across the country to target prevention and treatment activities.
Learn about promoting safe and responsible pain management, helping patients access treatment for opioid use disorder, and using data to target prevention and treatment.
Use this interactive Mapping Tool to explore geographic comparisons of the Part D opioid prescribing rate at the state, county, and ZIP code levels.
Visit the Ongoing Emergencies webpage to find information about opioid overdose prevention, treatment, and data, as well as to find links to the CMS Roadmap: Strategy to Fight the Opioid Crisis and the 2018 public health emergency declarations.
Visit HHS's National Opioids Crisis webpage to find more information and resources on the opioid crisis, including HHS's five-point strategy for combating the opioid addiction, crisis statistics, relevant articles, and real stories from providers, survivors, and caregivers.
SurgeonGeneral.gov provides an advisory on the overdose-reversing drug Naloxone and opioid overdose by highlighting information for patients and the public, as well as information for prescribers, substance use disorder treatment providers, and pharmacists.
The Office of Inspector General’s opioid analysis toolkit provides step-by-step instructions for using prescription drug data to identify patients who are at risk of opioid misuse or overdose.
Resources from Federal Partner Agencies
Visit the Truth Initiative’s Opioids webpage to find stories, information, and resources about opioid addiction.